MENU
IPSC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Century Therapeutics (IPSC) Earnings Date & Reports
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer... Show more
A.I. Advisor
published Earnings
IPSC is expected to report earnings to fall 29.41% to -11 cents per share on November 12
Q3'26
Est.
$-0.12
Q2'26
Missed
by $0.06
Q1'26
Beat
by $0.06
Q4'25
Beat
by $0.05
Q3'25
Missed
by $0.01
The last earnings report on August 12 showed earnings per share of -17 cents, missing the estimate of -10 cents. With 98.32K shares outstanding, the current market capitalization sits at 304.21M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
25 N 38th Street, 11th Floor
Phone
+1 267 817-5790
Employees
78
Web
https://www.centurytx.com